|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities | |
| Net Income Loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Depreciation and amortization | |
| Stock-based compensation | |
| Gain on receipt of nonmonetary tangible assets | |
| Change in right-of-use assets | |
| Non-cash issuance of warrants | |
| Change in warrant valuations and cancellations | |
| Inventory valuation adjustment | |
| Other | |
| Changes in operating assets and liabilities | |
| Accounts receivable | |
| Inventories | |
| Prepaid expenses and other assets | |
| Other long-term assets | |
| Accounts payable | |
| Accrued and other current liabilities | |
| Other long-term liabilities | |
| Net cash used in operating activities | |
| Cash flows from investing activities | |
| Purchase of intangible assets | |
| Purchases of property, equipment and software | |
| Net cash used in investing activities | |
| Cash flows from financing activities | |
| Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions | |
| Payment of deferred offering costs | |
| Proceeds from issuance of preferred stock, net of issuance costs | |
| Proceeds from exercise of stock options | |
| Proceeds from exercise of warrants | |
| Net cash provided by financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | |
| Net increase in cash and cash equivalents | |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period | |
| Supplemental disclosure of non-cash investing and financing activities | |
| Intangible assets in accounts payable, accrued and other long-term liabilities | |
| Gain on receipt of nonmonetary tangible asset | |
| Right-of-use assets obtained in exchange for new operating lease liabilities | |
| Non-cash deferred offering costs | |
| Deemed dividends |
Loading...